Incyte shares dip after earnings, guidance miss By Investing.com Stocks April 30, 2024 WILMINGTON – Incyte (NASDAQ:) Corporation (NASDAQ:INCY), a global biopharmaceutical company, reported first-quarter earnings that fell short of Wall Street expectations,…